Investigational Drug Information for NPC-06
✉ Email this page to a colleague
What is the drug development status for NPC-06?
NPC-06 is an investigational drug.
There have been 4 clinical trials for NPC-06.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Herpes Zoster, Acute Pain, and Herpes Simplex. The leading clinical trial sponsors are Nobelpharma and [disabled in preview].
Summary for NPC-06
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 830 |
WIPO Patent Applications | 432 |
Japanese Patent Applications | 50 |
Clinical Trial Progress | Phase 3 (2009-05-01) |
Vendors | 56 |
Recent Clinical Trials for NPC-06
Title | Sponsor | Phase |
---|---|---|
A Phase 3 Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster | Nobelpharma | Phase 3 |
NPC-06 to Acute Pain in Herpes Zoster | Nobelpharma | Phase 2 |
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer | Nobelpharma | Phase 2 |
Clinical Trial Summary for NPC-06
Top disease conditions for NPC-06
Top clinical trial sponsors for NPC-06
US Patents for NPC-06
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |